Unibest

Pharmaceutical intermediates

Brensocatib Intermediates

5 pharmaceutical intermediates for Brensocatib. Indication: Bronchiectasis.

提交项目All intermediates

About Brensocatib

Originator
AstraZeneca
Indication
Bronchiectasis

Available intermediates

5 intermediates currently listed for Brensocatib. Request specifications, documentation or a quotation for any item below.

Brensocatib intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
3-Methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3H-benzooxazol-2-one1220696-32-1//
(S)-4-(tert-butoxycarbonyl)-1,4-oxazepane-2-carboxylicacid1273567-44-4//
tert-butyl  (S)-(1-cyano-2-(4-iodophenyl)ethyl)carbamate1159489-37-8//
5-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-3-methyl-1,3-benzoxazol-2(3H)-one1802149-87-6//
tert-butyl (S)-(1-amino-3-(4-iodophenyl)-1-oxopropan-2-yl)carbamate868694-44-4//

Other programs under B

Baloxavir MarboxilBaricitinibBDTX-1535Bedaquiline FumarateBelumosudil mesylateBelzutifanBempedoic acidBeraprost Sodium

Building toward Brensocatib?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →